Literature DB >> 22075468

2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Bernard J Gersh, Barry J Maron, Robert O Bonow, Joseph A Dearani, Michael A Fifer, Mark S Link, Srihari S Naidu, Rick A Nishimura, Steve R Ommen, Harry Rakowski, Christine E Seidman, Jeffrey A Towbin, James E Udelson, Clyde W Yancy.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22075468     DOI： 10.1016/j.jacc.2011.10.825

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  57 in total

1.  Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR.

Authors:  Maxim Avanesov; Julia Münch; Julius Weinrich; Lennart Well; Dennis Säring; Christian Stehning; Enver Tahir; Sebastian Bohnen; Ulf K Radunski; Kai Muellerleile; Gerhard Adam; Monica Patten; Gunnar Lund
Journal:  Eur Radiol       Date:  2017-06-14       Impact factor: 5.315

Review 2.  Genetics of paediatric cardiomyopathies.

Authors:  Stephanie M Ware
Journal:  Curr Opin Pediatr       Date:  2017-10       Impact factor: 2.856

3.  Factors Associated with Uptake of Genetics Services for Hypertrophic Cardiomyopathy.

Authors:  Amirah Khouzam; Andrea Kwan; Samantha Baxter; Jonathan A Bernstein
Journal:  J Genet Couns       Date:  2015-01-08       Impact factor: 2.537

4.  Further Refining Risk in Hypertrophic Cardiomyopathy With Late Gadolinium Enhancement by CMR.

Authors:  Christopher M Kramer; Stefan Neubauer
Journal:  J Am Coll Cardiol       Date:  2018-08-21       Impact factor: 24.094

Review 5.  Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.

Authors:  Georgios K Efthimiadis; Efstathios D Pagourelias; Thomas Gossios; Thomas Zegkos
Journal:  World J Cardiol       Date:  2014-02-26

6.  The prognostic value of standardized reference values for speckle-tracking global longitudinal strain in hypertrophic cardiomyopathy.

Authors:  Gregory R Hartlage; Jonathan H Kim; Patrick T Strickland; Alan C Cheng; Nima Ghasemzadeh; Maria A Pernetz; Stephen D Clements; B Robinson Williams
Journal:  Int J Cardiovasc Imaging       Date:  2015-01-14       Impact factor: 2.357

Review 7.  Genetics of inherited cardiomyopathies in Africa.

Authors:  Gasnat Shaboodien; Timothy F Spracklen; Stephen Kamuli; Polycarp Ndibangwi; Carla Van Niekerk; Ntobeko A B Ntusi
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

8.  Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry.

Authors:  Stefan Neubauer; Paul Kolm; Carolyn Y Ho; Raymond Y Kwong; Milind Y Desai; Sarahfaye F Dolman; Evan Appelbaum; Patrice Desvigne-Nickens; John P DiMarco; Matthias G Friedrich; Nancy Geller; Andrew R Harper; Petr Jarolim; Michael Jerosch-Herold; Dong-Yun Kim; Martin S Maron; Jeanette Schulz-Menger; Stefan K Piechnik; Kate Thomson; Cheng Zhang; Hugh Watkins; William S Weintraub; Christopher M Kramer
Journal:  J Am Coll Cardiol       Date:  2019-11-12       Impact factor: 24.094

Review 9.  Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.

Authors:  Farbod Sedaghat-Hamedani; Elham Kayvanpour; Oguz Firat Tugrul; Alan Lai; Ali Amr; Jan Haas; Tanja Proctor; Philipp Ehlermann; Katrin Jensen; Hugo A Katus; Benjamin Meder
Journal:  Clin Res Cardiol       Date:  2017-08-24       Impact factor: 5.460

10.  Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography.

Authors:  Jérôme Peyrou; Patricia Réant; Amélie Reynaud; Claire Cornolle; Marina Dijos; Caroline Rooryck-Thambo; Mathieu Landelle; Michel Montaudon; François Laurent; Raymond Roudaut; Stéphane Lafitte
Journal:  Int J Cardiovasc Imaging       Date:  2016-06-20       Impact factor: 2.357
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.